Pouches, Ileoanal clinical trials at UCLA

1 research study open to eligible people

Showing trials for

  • Mirikizumab in the Treatment of Chronic Inflammatory Conditions of the Pouch

    open to eligible people ages 18-80

    The goal of this clinical trial is to learn if mirikizumab works to treat pouch disorders in adults. The main questions it aims to answer are: Does mirikizumab reduce symptoms of pouch disorders Participants will: Take mirikizumab every 4 weeks for one year Visit the clinic once every month for two months and at the end of the study Keep a diary of their symptoms

    Los Angeles, California and other locations

Our lead scientists for Pouches, Ileoanal research studies include .

Last updated: